CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Gentium Srl (ADR) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Gentium Srl (ADR)
Piazza XX Settembre, 2
Phone: +39 315373200p:+39 315373200 Villa Guardia, 22079  Italy Fax: +39 031385241f:+39 031385241

This company was Merged or Acquired on 2/21/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Gentium Srl is an Italy-based biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company’s development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The main shareholder of the Company is Jazz Pharmaceuticals PLC.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201312/31/2013YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer, Interim Scientific Director KhalidIslam 65 10/4/2011 11/9/2009
Chief Financial Officer, Chief Operating Officer SalvatoreCalabrese 51 10/1/2013 2/1/2005
Senior Vice President, Scientific Director CarinHeringa 52 3/1/2012 3/1/2012
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Gentium GmbH
GENTY
GNT

General Information
Number of Employees: 76 (As of 12/31/2013)
Outstanding Shares: 15,555,131 (As of 12/31/2013)
Shareholders: 3
Stock Exchange: OTC
Fax Number: +39 031385241
Email Address: gentium@gentium.it


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023